Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1658812rdf:typepubmed:Citationlld:pubmed
pubmed-article:1658812lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0001511lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0023546lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0038836lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0074112lld:lifeskim
pubmed-article:1658812lifeskim:mentionsumls-concept:C0083286lld:lifeskim
pubmed-article:1658812pubmed:issue4lld:pubmed
pubmed-article:1658812pubmed:dateCreated1991-12-13lld:pubmed
pubmed-article:1658812pubmed:abstractTextLeukotriene B4 (LTB4) induces a number of functional changes in human neutrophils, including both superoxide release and CD11b/CD18 (Mo1)-mediated adherence to various substrates, such as keyhole limpet hemocyanin (KLH). These effects are both time- and concentration-dependent. Neutrophil adhesion was at least 10-fold more sensitive to the stimulatory action of LTB4 than superoxide production. Two LTB4 receptor antagonists, LY255283 (1-(5-ethyl-2-hydroxy-4-(6-methyl-6-(1H-tetrazol-5-yl)heptyloxy )- phenyl)ethanone) and the sodium salt of SC-41930 (7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)-propoxy]-3,4-dihydro-8- propyl-2H- 1-benzopyran-2-carboxylic acid) were evaluated for effects on human neutrophil superoxide production and adhesion. Despite being more sensitive to LTB4-induced stimulation, neutrophil adhesion was at least 100-fold less sensitive to inhibition by LY255283 and SC-41930 than superoxide production. Both LTB4 receptor antagonists behaved similarly in these models. These compounds did not inhibit neutrophil responses induced by granulocyte/macrophage colony-stimulating factor (GM-CSF).lld:pubmed
pubmed-article:1658812pubmed:languageenglld:pubmed
pubmed-article:1658812pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:citationSubsetIMlld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1658812pubmed:statusMEDLINElld:pubmed
pubmed-article:1658812pubmed:monthAuglld:pubmed
pubmed-article:1658812pubmed:issn0952-3278lld:pubmed
pubmed-article:1658812pubmed:authorpubmed-author:SchultzR MRMlld:pubmed
pubmed-article:1658812pubmed:authorpubmed-author:SpaetheS MSMlld:pubmed
pubmed-article:1658812pubmed:authorpubmed-author:HerronD KDKlld:pubmed
pubmed-article:1658812pubmed:authorpubmed-author:SofiaM JMJlld:pubmed
pubmed-article:1658812pubmed:authorpubmed-author:MarderPPlld:pubmed
pubmed-article:1658812pubmed:issnTypePrintlld:pubmed
pubmed-article:1658812pubmed:volume43lld:pubmed
pubmed-article:1658812pubmed:ownerNLMlld:pubmed
pubmed-article:1658812pubmed:authorsCompleteYlld:pubmed
pubmed-article:1658812pubmed:pagination267-71lld:pubmed
pubmed-article:1658812pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:meshHeadingpubmed-meshheading:1658812-...lld:pubmed
pubmed-article:1658812pubmed:year1991lld:pubmed
pubmed-article:1658812pubmed:articleTitleEffects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production.lld:pubmed
pubmed-article:1658812pubmed:affiliationLilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285.lld:pubmed
pubmed-article:1658812pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1658812pubmed:publicationTypeIn Vitrolld:pubmed